- World rank, all time
- #21,150 of 42,892
- Rank in Brazil
- #322 of 870
- Research works
- 139 ▲ 82% vs 2013–17
- Citations
- 5k 36.0 per fractional work
- Top-10% rate
- 10.2% record average 16.5%
- Open access
- 39% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 9.8×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 9.8×
- Immunology and Microbiology 5.7×
- Veterinary 4.3×
- Medicine 2.7×
- Chemistry 2.6×
- Biochemistry, Genetics and Molecular Biology 2.2×
- Health Professions 1.6×
- Mathematics 0.7×
- Agricultural and Biological Sciences 0.7×
- Psychology 0.6×
- Neuroscience 0.6×
- Dentistry 0.6×
- Decision Sciences 0.4×
- Economics, Econometrics and Finance 0.3×
- Materials Science 0.2×
- Social Sciences 0.2×
- Engineering 0.2×
- Computer Science 0.1×
- Physics and Astronomy 0.1×
- Arts and Humanities 0.1×
- Environmental Science 0.0×
Who are the top researchers at Boehringer Ingelheim (Brazil)?
Ranked on the composite score, Richard M. Nelson lead among researchers whose main affiliation is Boehringer Ingelheim (Brazil).
- 1 Richard M. Nelson Brazil · #1,355,713 worldwide 35 citations · 15 works
Which keywords describe research at Boehringer Ingelheim (Brazil)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Fibrosis, TGF-ß, Interstitial Lung Disease, Epithelial-Mesenchymal Transition, Idiopathic Pulmonary Fibrosis, Myofibroblast, Epidemiology and Diagnosis.
- Heart Failure
- Endothelial Dysfunction
- Public Health
- Management
- Quality of Life
- Myofibroblast
- Diagnosis
- Interstitial Lung Disease
- Fibrosis
- Epidemiology
- TGF-ß
- Epithelial-Mesenchymal Transition
- Idiopathic Pulmonary Fibrosis
- Inflammation
- Global Burden
- Treatment
- Drug Discovery
- Respiratory
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 18 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 18 words, with their numbers
- Epidemiology3▲ 2.3×24 topics
- Fibrosis3▲ 50×4 topics
- TGF-ß3▲ 59×4 topics
- Interstitial Lung Disease2▲ 100×2 topics
- Epithelial-Mesenchymal Transition2▲ 63×2 topics
- Diagnosis2▲ 5.9×8 topics
- Idiopathic Pulmonary Fibrosis2▲ 125×1 topic
- Myofibroblast2▲ 125×1 topic
- Inflammation1▲ 2.4×14 topics
- Quality of Life1▲ 3.3×11 topics
- Global Burden1▲ 8.5×3 topics
- Management1▲ 5.6×3 topics
- Treatment1▲ 3.9×8 topics
- Public Health1▲ 2.8×8 topics
- Drug Discovery1▲ 17×3 topics
- Endothelial Dysfunction1▲ 17×4 topics
- Respiratory1▲ 39×2 topics
- Heart Failure1▲ 8.2×8 topics
Which research topics does Boehringer Ingelheim (Brazil) publish most on?
By volume in 2022–2025: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Chronic Obstructive Pulmonary Disease (COPD) Research, Systemic Sclerosis and Related Diseases and Chemical Synthesis and Analysis.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Pulmonary and Respiratory Medicine 2 works
- 2 Chronic Obstructive Pulmonary Disease (COPD) Research Pulmonary and Respiratory Medicine 1 works
- 3 Systemic Sclerosis and Related Diseases Pathology and Forensic Medicine 1 works
- 4 Chemical Synthesis and Analysis Molecular Biology 1 works
- 5 Renal Diseases and Glomerulopathies Nephrology 1 works
- 6 Pharmacogenetics and Drug Metabolism Pharmacology 0 works
- 7 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 0 works
- 8 Innovative Microfluidic and Catalytic Techniques Innovation Biomedical Engineering 0 works
- 9 Viral gastroenteritis research and epidemiology Infectious Diseases 0 works
- 10 Psoriasis: Treatment and Pathogenesis Immunology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Boehringer Ingelheim (Brazil)'s research output changed?
Output in 2018–2022 was 82% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in São Paulo
- Universidade de São Paulo
- Universidade Estadual Paulista (Unesp)
- Universidade Federal de São Paulo
- Pontifícia Universidade Católica de São Paulo
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Hospital Universitário da Universidade de São Paulo
- Universidade Brasil
- Universidade Presbiteriana Mackenzie
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.